Duke University Medical Center, Site 003 — Durham, North Carolina

Duke University Medical Center, Site 003 is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Duke University Medical Center, Site 003 has participated in 1 clinical trials.

Therapeutic areas: Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL).

Sponsors: Ariad Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke University Medical Center, Site 003?

Duke University Medical Center, Site 003 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke University Medical Center, Site 003 conducted?

Duke University Medical Center, Site 003 has 1 clinical trials on record. Their work covers Chronic Myeloid Leukemia (CML), Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL).

Is Duke University Medical Center, Site 003 accredited by Crixeo Health?

Duke University Medical Center, Site 003 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke University Medical Center, Site 003?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.